Skip to main content
# Title Department Research Year
201 Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV Department of Pharmaceutical Organic Chemistry 2021
202 Design, synthesis and mechanistic study of new 1,2,4-triazole derivatives as antimicrobial agents 2021
203 Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles Department of Pharmaceutics 2021
204 Synthesis, and biological evaluation of new series of pyrrol-2(3H)-one and pyridazin-3(2H)-one derivatives as tubulin polymerization inhibitors Department of Pharmaceutical Organic Chemistry 2021
205 Cytosolic aromatic dehydrogenase provides benzoic acid for xanthone biosynthesis in Hypericum Department of Pharmacognosy 2021
206 Untargeted Metabolomics Studies on Drug-Incubated Phragmites australis Profiles Department of Pharmacognosy 2021
207 GALA-Modified Lipid Nanoparticles for the Targeted Delivery of Plasmid DNA to the Lungs Department of Pharmaceutics 2021
208 Inversion Kinetics of Some E/Z 3-(Benzylidene)-2-Oxo-indoline Derivatives and Their In Silico CDK2 Docking Studies Department of Medicinal Chemistry 2021
209 Antibiofilm and antivirulence potential of silver nanoparticles against multidrug‐resistant Acinetobacter baumannii Department of Pharmaceutics 2021
210 Towards understanding of the interaction of certain carbapenems with protein via combined experimental and theoretical approach Department of Pharmaceutical Analytical Chemistry 2021